Browse 24936 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
June 19th, 2023 |
Promoting Research on Music and Health: Phased Innovation Award for Music Interventions (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
July 7th, 2021 |
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) |
National Institutes of Health |
August 10th, 2020 |
Boosting Frontline Health Workers' Ability in Responding to COVID-19 - Virtual Awareness and Capacity Building Training Project |
US Mission to Cameroon |
April 5th, 2021 |
PHS 2020-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) |
National Institutes of Health |
April 5th, 2021 |
PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) |
National Institutes of Health |
April 5th, 2021 |
PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) |
National Institutes of Health |
April 5th, 2021 |
PHS 2020-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) |
National Institutes of Health |
November 13th, 2020 |
Using Human Cell Animal Chimera Brains to Study HIV Latency and Pathology R01 - Clinical Trials Not Allowed |
National Institutes of Health |
April 5th, 2022 |
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed) |
National Institutes of Health |
April 5th, 2022 |
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) |
National Institutes of Health |
December 16th, 2020 |
Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) |
National Institutes of Health |
April 5th, 2022 |
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) |
National Institutes of Health |
August 24th, 2020 |
Delta Health Care Service Grant Program |
Business and Cooperative Programs |
October 14th, 2020 |
Development of Standard Core Clinical Outcomes Assessments (COAs) and Endpoints (UG3/UH3 Clinical Trial Optional) |
Food and Drug Administration |
October 13th, 2020 |
Renewal-Harmonization of Technical Requirements for Pharmaceuticals for Human Use (U01) Clinical Trials Not Allowed |
Food and Drug Administration |
September 24th, 2020 |
Tobacco Use and HIV in Low and Middle-Income Countries (U01 Clinical Trial Optional) |
National Institutes of Health |
September 8th, 2020 |
Noncommunicable Disease Prevention and Health Promotion in the Region of the Americas, PAHO. |
Centers for Disease Control CGH |
May 7th, 2023 |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity) |
National Institutes of Health |
November 4th, 2020 |
Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required) |
National Institutes of Health |
November 4th, 2020 |
Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required) |
National Institutes of Health |
|
May 30th, 2023 |
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
September 15th, 2020 |
Technical Collaboration to Strengthen and Expand Capacity to Assess, Prevent, and Mitigate the Effects of Public Health Threats of National and Global Importance with the Ministry of Health in Lao PDR |
Centers for Disease Control CGH |
February 17th, 2021 |
Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
October 21st, 2020 |
Biomarkers of Dietary Intake and Exposure Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
October 21st, 2020 |
Biomarkers of Dietary Intake and Exposure (U2C Clinical Trial Required) |
National Institutes of Health |
August 19th, 2020 |
National Public Health Surveillance for Chemical and Radiologic Exposures and Emerging Drug Threats - COVID-19 Supplemental |
Centers for Disease Control NCEH |
July 16th, 2020 |
Improved Health Services and Systems in the North of Mali |
Mali USAID Bamako |
November 10th, 2020 |
Continuation of the Human Pancreas Analysis Program (HPAP) for Type 1 Diabetes (HPAP-T1D) (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
December 8th, 2020 |
Advancing Population-Based Surveillance of Birth Defects |
Centers for Disease Control NCBDDD |
December 10th, 2020 |
Non-invasive Diagnostics to Improve Gynecologic Health (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
July 31st, 2020 |
Improving Clinical and Public Health Outcomes through National Partnerships to Prevent and Control Emerging and Re-Emerging Infectious Disease Threats |
Centers for Disease Control NCEZID |
September 3rd, 2020 |
FY 2021 RSVP Competition |
Corporation for National and Community Service |
September 28th, 2020 |
Network of the National Library of Medicine Evaluation Center (U24) (Clinical Trial Not Allowed) |
National Institutes of Health |
November 15th, 2023 |
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2023 |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) |
National Institutes of Health |
September 14th, 2021 |
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2023 |
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) |
National Institutes of Health |
November 12th, 2020 |
PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional) |
National Institutes of Health |
May 25th, 2022 |
NICHD Research Education Programs (R25 Clinical Trial Not Allowed) |
National Institutes of Health |
November 19th, 2020 |
Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed) |
National Institutes of Health |